Analyst
BTS Capital
Equibles does not estimate personal net worth.
Herschel is recorded as Analyst at BTS Capital. Herschel has spoken on 1 earnings call across 1 company, most recently for Jagsonpal Pharmaceuticals Limited on July 30, 2026. The companies whose calls Herschel spoke on are classified in the Healthcare sector.
“My question is related to Maintain brand. Basically, if I look at the growth profile of Maintain, most of our company's growth has been coming from that molecule itself.”
BTS Capital
Analyst
Transcript header (unverified)
Jagsonpal Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Jagsonpal Pharmaceuticals Limited
